Copyright
©The Author(s) 2020.
World J Gastroenterol. Dec 28, 2020; 26(48): 7664-7678
Published online Dec 28, 2020. doi: 10.3748/wjg.v26.i48.7664
Published online Dec 28, 2020. doi: 10.3748/wjg.v26.i48.7664
Figure 2 CD31 staining and prostate-specific membrane antigen staining.
A: Positive control, CD31 staining in human tonsils (400 ×, scale bar = 100 μm); B: Negative control, CD31 staining in human tonsils (400 ×, scale bar = 100 μm); C: Anti-prostate-specific membrane antigen (PSMA) positive control, PSMA staining in human prostate cancer tissues (400 ×); D: Anti-PSMA negative control, PSMA staining in human prostate cancer tissues (400 ×).
- Citation: Chen LX, Zou SJ, Li D, Zhou JY, Cheng ZT, Zhao J, Zhu YL, Kuang D, Zhu XH. Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis. World J Gastroenterol 2020; 26(48): 7664-7678
- URL: https://www.wjgnet.com/1007-9327/full/v26/i48/7664.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i48.7664